Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

BUFFALO, N.Y. — In January, Nicole Albanese, PharmD, clinical associate professor of pharmacy practice in the University at ...

Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...

If you're starting a semaglutide GLP-1 RA medication like Wegovy or Ozempic for weight loss, you may be wondering how soon ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...

Are we returning to a world where ‘slim’ is yet again being seen as the ideal body image? The concept of the ideal body has ...

Plus, salon owners are seeing a massive drawdown in clients coming in for their regular scheduled appointments, citing ...

Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men’s performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent ...